Publications by authors named "Beth Borowsky"

25Publications

Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data.

Cortex 2017 07 15;92:139-149. Epub 2017 Apr 15.

School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cortex.2017.04.001DOI Listing
July 2017

Sleep deficits but no metabolic deficits in premanifest Huntington's disease.

Ann Neurol 2015 Oct 21;78(4):630-48. Epub 2015 Aug 21.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832311PMC
October 2015

Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches.

Mov Disord 2014 Sep;29(11):1419-28

CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26021DOI Listing
September 2014

HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.

Mov Disord 2014 Sep 7;29(10):1281-8. Epub 2014 Jul 7.

School of Psychological Sciences, Monash University, Clayton, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25964DOI Listing
September 2014

Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.

Brain Struct Funct 2015 Jan 16;220(1):501-12. Epub 2013 Nov 16.

School of Psychology and Psychiatry, Monash University, Clayton, VIC, 3800, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00429-013-0670-zDOI Listing
January 2015

Assessment of cognitive symptoms in prodromal and early huntington disease.

PLoS Curr 2011 Oct 25;3:RRN1250. Epub 2011 Oct 25.

Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Department of Psychiatry and Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD USA; Translational Medicine, CHDI Foundation, Inc., Princeton NJ; University of Manchester, Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; CHDI Foundation, Inc.; Huntington's Disease Drug Works, Lake Forest Park, WA; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada; School of Psychology and Clinical Language Sciences, University of Reading, U.K.; Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA; School of Psychology and Psychiatry, Monash University, Melbourne, Australia and CNS Drug Development consultant.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201666PMC
October 2011

Assessment of depression, anxiety and apathy in prodromal and early huntington disease.

PLoS Curr 2011 Jun 17;3:RRN1242. Epub 2011 Jun 17.

Research Methods, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada; Department of Psychiatry and Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD USA; AP-HP, centre de référence maladie de Huntington; INSERM U955 E01- Ecole Normale Supérieure-University Paris Est, Neuropsychologie interventionnelle laboratory,Créteil- Paris, France; Translational Medicine, CHDI Foundation, Inc., Princeton NJ; University of Manchester, Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Neurology, University of Utah, Salt Lake City UT USA; CHDI Foundation, Inc.; Departments of Neurology and Psychiatry, Beth Israel Medical Center, New York, NY; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario Canada; School of Psychology and Clinical Language Sciences, University of Reading, U.K.; Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway & Department of Neurology, Stavanger University Hospital, Stavanger, Norway; Department of Psychiatry, Leiden University Medical Centre, Leiden, Netherlands and CNS Drug Development consultant.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124013PMC
June 2011